Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
3.250
-0.130 (-3.85%)
At close: Mar 10, 2026, 4:00 PM EDT
3.330
+0.080 (2.46%)
After-hours: Mar 10, 2026, 6:28 PM EDT
Exagen Revenue
In the year 2025, Exagen had annual revenue of $66.58M with 19.65% growth. Exagen had revenue of $16.63M in the quarter ending December 31, 2025, with 21.79% growth.
Revenue (ttm)
$66.58M
Revenue Growth
+19.65%
P/S Ratio
1.14
Revenue / Employee
$309,651
Employees
215
Market Cap
73.66M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 66.58M | 10.93M | 19.65% |
| Dec 31, 2024 | 55.64M | 3.09M | 5.89% |
| Dec 31, 2023 | 52.55M | 6.99M | 15.33% |
| Dec 31, 2022 | 45.56M | -2.74M | -5.66% |
| Dec 31, 2021 | 48.30M | 6.32M | 15.07% |
| Dec 31, 2020 | 41.98M | 1.59M | 3.93% |
| Dec 31, 2019 | 40.39M | 7.95M | 24.50% |
| Dec 31, 2018 | 32.44M | 5.63M | 21.01% |
| Dec 31, 2017 | 26.81M | 8.86M | 49.38% |
| Dec 31, 2015 | 17.95M | 6.28M | 53.87% |
| Dec 31, 2014 | 11.66M | 8.61M | 281.77% |
| Dec 31, 2013 | 3.06M | 2.13M | 229.91% |
| Dec 31, 2012 | 926.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Myriad Genetics | 824.50M |
| Inotiv | 514.03M |
| Fulgent Genetics | 322.67M |
| MDxHealth | 107.88M |
| FONAR | 106.03M |
| Prenetics Global | 92.39M |
| Biodesix | 88.50M |
| Burning Rock Biotech | 75.75M |
XGN News
- 6 hours ago - Exagen Inc. (XGN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 17 hours ago - Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results - GlobeNewsWire
- 7 days ago - Exagen Inc. to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 14 days ago - Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026 - GlobeNewsWire
- 2 months ago - Exagen Inc. Announces Select Preliminary 2025 Financial Results - GlobeNewsWire
- 4 months ago - Exagen Inc. to Participate in Fourth Quarter Investor Conferences - GlobeNewsWire
- 4 months ago - Exagen Inc. (XGN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Exagen Inc. Reports Strong Q3 2025 Results - GlobeNewsWire